These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 22030468

  • 21. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
    Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, Zimmermannc R, Bühner M, Konopka K, Rupprecht R, Baghai TC.
    J Psychiatr Res; 2014 Jun; 53():76-83. PubMed ID: 24655586
    [Abstract] [Full Text] [Related]

  • 22. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C, Zill P, Baghai TC, Eser D, Zwanzger P, Wenig N, Rupprecht R, Bondy B.
    Psychoneuroendocrinology; 2006 Sep; 31(8):1019-25. PubMed ID: 16890377
    [Abstract] [Full Text] [Related]

  • 23. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 24. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 25. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
    Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel JC, Sonntag A, Steiger A.
    Neuropsychopharmacology; 2006 Apr; 31(4):832-44. PubMed ID: 16237393
    [Abstract] [Full Text] [Related]

  • 26. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M, Bschor T, Bauer M, Lucka C, Lewitzka U, Ising M, Uhr M, Mueller-Oerlinghausen B, Baethge C.
    Neuropsychobiology; 2009 Apr; 60(1):23-30. PubMed ID: 19684420
    [Abstract] [Full Text] [Related]

  • 27. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
    Nothdurfter C, Schmotz C, Sarubin N, Baghai TC, Laenger A, Lieb M, Bondy B, Rupprecht R, Schüle C.
    J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
    [Abstract] [Full Text] [Related]

  • 28. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 29. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Jul; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 30. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):797-802. PubMed ID: 8750037
    [Abstract] [Full Text] [Related]

  • 31. The stress hormone system in various sleep disorders.
    Lattova Z, Keckeis M, Maurovich-Horvat E, Wetter TC, Wilde-Frenz J, Schuld A, Pollmächer T.
    J Psychiatr Res; 2011 Sep 15; 45(9):1223-8. PubMed ID: 21501849
    [Abstract] [Full Text] [Related]

  • 32. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L.
    J Affect Disord; 2007 Dec 15; 104(1-3):83-90. PubMed ID: 17467808
    [Abstract] [Full Text] [Related]

  • 33. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):803-7. PubMed ID: 8750038
    [Abstract] [Full Text] [Related]

  • 34. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
    Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM.
    J Psychiatr Res; 2004 Dec 15; 38(6):553-7. PubMed ID: 15458850
    [Abstract] [Full Text] [Related]

  • 35. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
    Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F.
    Exp Clin Endocrinol Diabetes; 1996 Dec 15; 104(1):31-7. PubMed ID: 8750568
    [Abstract] [Full Text] [Related]

  • 36. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB.
    Biol Psychiatry; 2005 Feb 15; 57(4):336-42. PubMed ID: 15705348
    [Abstract] [Full Text] [Related]

  • 37. A single DEX/CRH test in male drug-free depressed patients is associated with the clinical response to treatment with fluoxetine.
    Paslakis G, Heuser I, Schweiger U, Deuschle M.
    J Psychiatr Res; 2010 Dec 15; 44(16):1154-7. PubMed ID: 20447650
    [Abstract] [Full Text] [Related]

  • 38. Discrimination between patients with melancholic depression and healthy controls: comparison between 24-h cortisol profiles, the DST and the Dex/CRH test.
    Paslakis G, Krumm B, Gilles M, Schweiger U, Heuser I, Richter I, Deuschle M.
    Psychoneuroendocrinology; 2011 Jun 15; 36(5):691-8. PubMed ID: 21035272
    [Abstract] [Full Text] [Related]

  • 39. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
    Hundt W, Zimmermann U, Pöttig M, Spring K, Holsboer F.
    Alcohol Clin Exp Res; 2001 May 15; 25(5):687-91. PubMed ID: 11371718
    [Abstract] [Full Text] [Related]

  • 40. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
    Heuser I, Yassouridis A, Holsboer F.
    J Psychiatr Res; 1994 May 15; 28(4):341-56. PubMed ID: 7877114
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.